Nvidia Outperforms; Avidity Biosciences Rallies; Carter's Falls

On this episode of Stock Movers:
- Nvidia (NVDA) leads Magnificent Seven stocks higher in the US premarket Monday, with traders optimistic about the US and China closing in on a trade deal. Trade negotiators from China and the US announced Sunday that they’d struck a slew of agreements on issues spanning tariffs, shipping fees, fentanyl and export controls over two days in Malaysia.
- Avidity Biosciences (RNA) shares rally in premarket trading after Novartis (NOVN) agreed to buy the biotechnology company in a deal valued at $12 billion. It marks the Swiss drugmaker’s biggest acquisition in more than a decade and adds several potential blockbuster treatments as generic competition looms for its current top-sellers.
- Carter's (CRI) shares fall ahead of the open after the children’s apparel company reported net sales for the third quarter that missed the average analyst estimate. The company also plans to reduce offices-based roles by about 15% by the end of 2025, and it boosted the amount of stores it plans to close.

See omnystudio.com/listener for privacy information.